Johnson & Johnson (JNJ) Tops Q3 EPS by 7c; Boosts FY14 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Johnson & Johnson (JNJ) PT, Estimates Cut at BofA/Merrill Lynch Post Q3
October 15, 2014 7:23 AM EDTBofA/Merrill Lynch analyst Bob Hopkins lowered his price target on Johnson & Johnson (NYSE: JNJ) to $99.00 (from $106.00) while reiterated a Neutral rating following 'solid' Q3 results.
Hopkins said while solid the quarter also highlighted a number of likely EPS headwinds for... More



